Products

MoleculePresentationStatusTherapeutic Area
Alendronic acid  70 mg x   4 tabletsMA and DossierFOR THE TREATMENT OF BONE DISEASE - BISPHOSPHONATE
70 mg x 12 tabletsMA and Dossier
Amoxicillin1 g  12 tabletsMA and DossierANTIBACTERIAL FOR SYSTEMIC USE - PENICILLIN
Amoxicillin and clavulanic acid875 + 125 mg  tablets and sachetsMA  and DossierANTIBACTERIAL FOR SYSTEMIC USE - PENICILLIN IN ASSOCIATION
pediatric sachetsUnder development
Atorvastatin10 mg x 30 tabletsMA  and DossierMODIFYING SUBSTANCE OF LIPIDS -
HMG-CoA REDUCTASE INHIBITOR - (STATIN)
 20 mg x 30 tablets MA  and Dossier
40 mg x 30 tablets MA  and Dossier
80 mg x 30 tabletsMA  and Dossier
Calcium Levofolinate7,5 mg x 10 tabletsUnder developmentTHERAPEUTIC PRODUCT - DETOXIFYING SUBSTANCE FOR ANTINEOPLASTIC TREATMENTS - ANTIDOTE
   4 mg x 30 tabletsUnder development
Calcium Levofolinate Lyophilized 25 mg vialMA  and DossierTHERAPEUTIC PRODUCT - DETOXIFYING SUBSTANCE FOR ANTINEOPLASTIC TREATMENTS -ANTIDOTE
100 mg vialMA  and Dossier
175 mg vialMA  and Dossier
Calcium Levofolinate solution25 mg/2,5 ml vialMA  and DossierTHERAPEUTIC PRODUCT - DETOXIFYING SUBSTANCE FOR ANTINEOPLASTIC TREATMENTS -ANTIDOTE
50 mg/ 5 ml vialMA  and Dossier
100 mg/10 ml vialMA  and Dossier
175 mg/17,5 ml vialMA  and Dossier
Cefazolina1000 mg/4 ml powder and solvent for injectable solution i.m.MA  and DossierANTIBACTERIAL FOR SYSTEMIC USE - CEPHALOSPORINE OF FIRST GENERATION
Ceftazidima 1 g/3 ml powder and solvent for injectable solution i.m.MA  and DossierANTIBACTERIAL FOR SYSTEMIC USE - THIRD-GENERATION CEPHALOSPORINE
1 g /10 ml powder and solvent  for injectable solution e.v.MA  and Dossier
2 g  powder for solution infusionMA  and Dossier
Ceftriaxone 250 mg/ 2 ml - powder and solvent for injectable solution i.m.MA  and DossierANTIBACTERIAL FOR SYSTEMIC USE - THIRD-GENERATION CEPHALOSPORINE
500 mg/ 2 ml - powder and solvent for injectable solution i.m.MA  and Dossier
1 gr/3,5 ml -  powder and solvent for injectable solution i.m.MA  and Dossier
1 g / 10 ml powder and solvent  for injectabble solution e.v.MA  and Dossier
2 g  powder for solution for infusionMA  and Dossier
Cilostazole100 mg x 28 tabletsMA  and DossierANTITHROMBOTIC
PLASTIC ANTI-AGING
Ciprofloxacin250 mg x  10 tabletsMA  and DossierANTIBACTERIALS FOR SYSTEMIC USE - KINOLONIC ANTIBACTERIALS
500 mg x  6 tabletsMA  and Dossier
 750 mg x 12 tabletsMA  and Dossier
Citalopram drops40 mg/mlDossierANTIDEPRESSANT -SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI)
Clodronic Acid + lidocaine100 mg / 3,3 ml 6 vialsDossierFOR THE TREATMENT OF BONE DISEASE - BISPHOSPHONATE
200 mg/ 4 ml 3 vials Dossier
Desketoprofene25 mg 20 tabletsMA  and DossierANTI-INFLAMMATORY AND ANTIREHUMATIC,  NOT STEROID
 25 mg oral solution stick packMA  and Dossier
Dutasteride0,5 mg x 30 capsulesMA  and DossierDRUG USED IN BENIGNA PROSTATIC HYPERTROPHY
Escitalopram drops20 mg /ml -  bottle 15 mlMA  and DossierANTIDEPRESSANT -
SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRI)
Finasteride 1 mg x 28 tabletsMA  and DossierDRUG USED FOR STATES OF ANDROGENETIC ALOPECIA IN MEN
5 mg x 15 tabletsMA  and DossierDRUG USED IN BENIGNA PROSTATIC HYPERTROPHY 
Fosfomycin Trometamol 3 g granular for solution -  2 sachetsMA  and DossierANTIBACTERIAL FOR SYSTEMIC USE 
Furosemide  25 mg x 30 tablets DossierDIURETIC - DIURETIC FOR HIGHER DIURETIC ACTION -
NON-ASSOCIATED SULPHONAMID
500 mg x 20 tablets Dossier
Ibandronate150 mg x  3 tabletsMA  and DossierFOR THE TREATMENT OF BONE DISEASE - BISPHOSPHONATE
Manidipine10 mg x  28 tabletsMA and DossierCALCIUM-ANTAGONIST
20 mg x 28  tabletsMA and Dossier
Metformina500 mg, 30-50 tablets Under registration FOR THE TREATMENT OF TYPE 2 DIABETES - BIGUANIDE
850 mg, 30-40 tabletsUnder registration
850 mg, 40 tabletsUnder registration
1000 mg, 60 tabletsUnder registration
Montelukast10 mg x 28 tabletsMA  and DossierFOR OBSTRUCTIVE AIRWAY SYNDROMES FOR SYSTEMIC USE - ANTAGONIST OF LEUCOTRIENIC RECEPTORS
 4 mg x 28 tabletsMA  and Dossier
 5 mg x 28 tabletsMA  and Dossier
Nebivolole  5 mg x  28 tabletsMA  and DossierSELECTIVE BETA BLOCKER -
FOR THE TREATMENT OF HYPERTENSION
Omeprazole10 mg x 14-28 capsulesMA  and DossierFOR DISORDERS RELATED TO ACID SECRETION - FOR THE TREATMENT OF PEPTIC ULCER AND GASTROESOGACEOUS REFLUX DISEASE -
PROTON-PUMP INHIBITORS (PPIs)
20 mg x 14-28 capsulesMA  and Dossier
40 mg x 14-28 capsulesMA  and Dossier
Pantoprazole (OTC)20 mg x 7 - 14 tabletsMA and DossierFOR DISORDERS RELATED TO ACID SECRETION - FOR THE TREATMENT OF PEPTIC ULCER AND GASTROESOGACEOUS REFLUX DISEASE -
PROTON-PUMP INHIBITORS (PPIs)
Paroxetine drops10 mg/ml oral drops, solutionUnder registrationANTIDEPRESSANT -SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI)
Prednisone  5 mg x 20 tabletsMA  and DossierSYSTEMIC CORTICOSTEROID - GLUCOCORTICOID
  5 mg x 10 tabletsMA  and Dossier
25 mg x 10 tabletsMA  and Dossier
VITAMIN D3soft gel capsules:  10.000 U.I.Under registrationVITAMIN D
soft gel capsules:  25.000 U.I.Under registration
soft gel capsules:  50.000 U.I.Under registration
soft gel capsules: 100.000 U.I.Under registration
injectable: 100.000 U.I.Under registration
injectable: 300.000 U.I.Under registration